MBRXMoleculin Biotech, Inc.

MBRX Stock Price, Valuation & Chart | Moleculin Biotech, Inc.

Compare

$0.690+0.04 (+6.77%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology MBRX intrinsic value MBRX calculated fair value vs price

Overview Financials Dividends Ratios

MBRX Historical price chart

MBRX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization3.70M

PE Ratio-0.05

EPS-15.37

Trading Volume348.23K

Today's High/Low0.7/0.64

Dividend Yield0.00

52 Week High/Low15.75/0.16

Shares Outstanding5.34M

MBRX Financial Statement

MBRX Analyst ratings

MBRX Analysis & performance metrics

MBRX Company profile

Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its…

Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship…

MBRX Management team

Name

Position

Walter V. KlempCEO

Co-Founder, Chairman, President & Chief Executive Officer

Waldemar Priebe Ph.D.

Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

Donald H. Picker Ph.D.

Chief Scientific Officer

John Paul Waymack M.D., Sc.D.

Senior Chief Medical Officer

Jonathan P. Foster CPACFO

Executive Vice President & Chief Financial Officer

Name

Position

Walter V. KlempCEO

Co-Founder, Chairman, President & Chief Executive Officer

Waldemar Priebe Ph.D.

Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

Donald H. Picker Ph.D.

Chief Scientific Officer

John Paul Waymack M.D., Sc.D.

Senior Chief Medical Officer

Jonathan P. Foster CPACFO

Executive Vice President & Chief Financial Officer

Management Team

Walter V. KlempCEO

Co-Founder, Chairman, President & Chief Executive Officer

Waldemar Priebe Ph.D.

Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

Donald H. Picker Ph.D.

Chief Scientific Officer

John Paul Waymack M.D., Sc.D.

Senior Chief Medical Officer

Jonathan P. Foster CPACFO

Executive Vice President & Chief Financial Officer

Management

Walter V. KlempCEO

Co-Founder, Chairman, President & Chief Executive Officer

Waldemar Priebe Ph.D.

Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

Donald H. Picker Ph.D.

Chief Scientific Officer

John Paul Waymack M.D., Sc.D.

Senior Chief Medical Officer

Jonathan P. Foster CPACFO

Executive Vice President & Chief Financial Officer

Total 5 executives

MBRX Frequently asked questions

What is Moleculin Biotech, Inc. (MBRX) Stock Price?

Current stock price of Moleculin Biotech, Inc. (MBRX) stock is $0.690. The stock price is +6.77% higher in the session. The intraday range can be seen from this page. Volume of Moleculin Biotech, Inc. (MBRX) stock is 348.23K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Moleculin Biotech, Inc. (MBRX) stock price going up or down today?

The stock price of Moleculin Biotech, Inc. (MBRX) can change with earnings, company news, and overall market sentiment. Moleculin Biotech, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Moleculin Biotech, Inc. stock expensive at its current price?

Whether Moleculin Biotech, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MBRX on this page is -0.05. EPS on this page is -15.37. Compare those figures with peers and growth expectations before deciding if the current Moleculin Biotech, Inc. price is justified.

How has the stock price of Moleculin Biotech, Inc. (MBRX) performed historically?

Historical performance for Moleculin Biotech, Inc. (MBRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MBRX reacted to past earnings and market events.

Should I buy Moleculin Biotech, Inc. (MBRX) stock, at this price?

Buying Moleculin Biotech, Inc. (MBRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.